Telomere Length Emerges as Key Biomarker for Heart Disease Risk
New review reveals how telomere shortening drives cardiovascular aging and identifies promising therapeutic targets for heart health.
20 articles
New review reveals how telomere shortening drives cardiovascular aging and identifies promising therapeutic targets for heart health.
A 2025 review maps the molecular drivers of cardiac aging and evaluates drugs, CRISPR, stem cells, and lifestyle as countermeasures.
Dive deep into the molecular mechanisms of vascular aging and explore cutting-edge interventions β from senolytic therapies and nitric oxide restoration to exercise-induced remodeling and emerging pharmacological approaches β that are redefining what's possible in cardiovascular longevity.
A new review examines how drugs that clear senescent cells could transform treatment of age-related cardiovascular disease.
Novel liposome therapy delivers miR-10a to atherosclerotic plaques, reprogramming inflammatory macrophages and reducing disease progression in mice.
Major analysis of 38,089 older adults shows aggressive lipid-lowering therapy significantly reduces cardiovascular events.
Advanced cholesterol-lowering therapies show promise for dramatically reducing cardiovascular disease risk through innovative approaches.
Natural isoflavone prevents cardiac enlargement through novel mitochondrial protection pathway, offering new therapeutic approach.
A new review reveals how sirtuin enzymes regulate cardiac fibrosis and why targeting them could reshape heart failure treatment.
A 2025 review maps the molecular mechanisms driving cardiovascular agingβfrom inflammaging to ECM remodelingβand outlines emerging therapies.
Cas13-based RNA editing shows promise for treating hereditary hypertrophic cardiomyopathy by correcting disease-causing mutations at the RNA level.
Evidence-based training strategies for cardiovascular health, muscle strength, and longevity from leading exercise researchers.
Scientists reveal CFTR protein prevents cardiomyocyte senescence by reducing mitochondrial oxidative stress via a newly discovered deubiquitination pathway.
New telerehabilitation system aims to improve exercise adherence and cardiovascular outcomes after heart attacks.
A landmark Circulation review reveals how aging blood vessels accelerate systemic decline β and outlines emerging therapies to stop it.
Researchers created synthetic immune receptors that boost macrophages' ability to clear cellular debris, reducing inflammation in liver and heart disease.
Scientists discover how to enhance cancer immunotherapy by converting tumor-supporting immune cells into tumor-fighting ones.
A feedforward ANGPT-TIE2 signaling loop amplifies PIK3CA-driven venous malformations, pointing to TIE2 inhibition as a more effective therapy than mTOR blockade.
A pilot trial explores whether intentionally inducing brief daily dyssynchrony via pacemaker can retrain failing heart muscle in humans.
Sotatercept emerges as potential treatment for combined pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction.